Dogwood Therapeutics logo

Dogwood Therapeutics

DWTXXNAS

Dogwood Therapeutics is a pharmaceutical preparations company trading on XNAS, led by CEO Gregory Duncan, with a market cap of $66.1M.

Market Cap$66.1M
Employees4.0
CEOGregory Duncan
CountryUnited States of America
PHARMACEUTICAL PREPARATIONS
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric
DWT

Dogwood Therapeutics FAQ

Common questions about Dogwood Therapeutics

Dogwood Therapeutics is scheduled to report earnings for Q1 2026 on May 7, 2026.

Dogwood Therapeutics has approximately 4 employees.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.